Antibody binding to porcine sialoadhesin reduces phagocytic capacity without affecting other macrophage effector functions
Highlights
► Sn is a macrophage-restricted endocytic receptor and a target for immunotherapy. ► The effect of mAb binding to pSn on macrophage viability and functions was tested. ► Phagocytosis, OVA-DQ processing, ROI and cytokine production, MHC I/II expression. ► mAb binding to Sn causes a decrease in phagocytosis, not affecting other functions. ► Possible implications on homeostasis, infectious/immune diseases, immunotherapy.
Introduction
Macrophages perform essential roles in the immune system of humans and animals in steady state conditions and inflammation [1], [2]. In the innate immune system they play pivotal roles in the cellular host defence against infection and in tissue remodeling and repair. The overproduction of chemokines and inflammatory cytokines by macrophages during inflammation is a crucial event for triggering the progressive recruitment and activation of immune cells [3], where they are at the crossroads with adaptive immunity. Additionally, they are specialized in chemotaxis, killing of invading microorganisms, uptake of microbes, infected or apoptotic cells and molecules, repairing damaged tissues, controlling the inflammatory response and preventing excessive tissue damage by their anti-inflammatory properties [4], [5], [6], [7], [8], [9]. Another important macrophage property at the interface between the innate and the adaptive immune system is the processing and presentation of endogenous or internalized antigens [10], [11], [12] or the presentation of captured antigens [13], [14]. These various functions can be exerted by different populations of functionally heterogeneous macrophages, which is reflected by their phenotypical diversity [1]. Depending on their tissue site and activation status, a range of macrophages can be found, from resting resident to fully activated inflammatory macrophages [9], each expressing various receptors enabling them to exercise their respective functions [15].
Sialoadhesin (Sn, Siglec-1, CD169) is a macrophage-restricted receptor that was first described as a sialic acid-dependent sheep erythrocyte receptor (SER) involved in lymphocyte interactions [16], [17], [18]. Sn is a member of the family of sialic acid-binding immunoglobulin (Ig)-like lectins (siglecs) [19], which are expressed in a cell type specific manner on cells of the hematopoietic and immune system [20], with the exception of MAG (Siglec-4), which is expressed in the nervous system [21], and Siglec-6, expressed in human placenta [22]. The expression of Sn is highly regulated and under normal physiological conditions Sn can only be found at high levels on distinct subsets of tissue-resident macrophages, but not on its precursor cells, the monocytes [17], [23]. Upon exposure to inflammatory stimuli, however, Sn can rapidly be upregulated in macrophages and monocytes, suggesting a role for Sn in macrophage-mediated inflammatory responses [20]. Abundant Sn expression is seen in chronic inflammatory diseases such as rheumatoid arthritis and atherosclerosis [24], [25], and on tumor-infiltrating macrophages in breast cancer tumors [26].
Sn is a type I transmembrane protein with a very large extracellular region, consisting of 1 N-terminal variable (V) Ig-like domain followed by 16 constant Ig-like domains of type C2 [27]. The extended structure of Sn is thought to promote interactions of macrophages with host cells and with the extracellular matrix, which relate to homeostasis and immunity [23], [28]. Via its distal N-terminal domain Sn can bind promiscuously to many sialylated glycoconjugates, with a preference for O-linked oligosaccharides terminating in Neu5Acα2,3Galβ1,3GalNAc [29], [30]. Besides this, binding of Sn to membrane receptors via a sialic acid-independent mechanism has also been described [31], [32]. In addition to its role in cell–cell interactions, Sn has also been shown to facilitate interactions with a variety of pathogens including viruses (HIV-1, human rhinoviruses and PRRSV; [33], [34], [35]), bacteria (Campylobacter jejuni and Neisseria meningitides; [36], [37]) and a parasite (Trypanosoma cruzi; [38]). Porcine Sn (pSn) was shown to be a clathrin-dependent endocytic receptor and to mediate uptake of sialylated bacterial and viral pathogens [36], [39]. Furthermore, it was established that porcine primary alveolar macrophages (PAM) expressing pSn internalized pSn upon binding of a pSn-specific monoclonal antibody (mAb) [39], [40], [41]. Additionally, it was assessed that a pSn-specific immunotoxin and an immunoconjugate of the model antigen human serum albumin linked to a pSn-specific mAb were also internalized into porcine PAM together with pSn [41]. Overall, these data demonstrate the involvement of Sn in internalization processes. Given its restricted expression pattern and its potential to internalize, Sn is gaining interest as a potential target in immunotherapy [40], [41], [42], [43], [44], [45]. The receptor is well suited for a ‘Trojan horse’ strategy, whereby therapeutic agents conjugated to an antibody or a multimeric glycan ligand are carried into the cell [41], [42], [45], [46]. Sn could be used to specifically target antigens, toxins, drugs or other molecules to macrophages, either to specifically eliminate, activate or immunomodulate these cells or to prevent ligand binding to Sn.
Apart from its large extracellular domain, Sn also contains a transmembrane domain and a short cytoplasmic domain, which is poorly conserved between mammalian species [28]. In contrast to most other siglecs, these domains are devoid of tyrosine-based motifs that are implicated in signal transduction and endocytosis, and do not associate with the DAP-12 (12 kDa DNAX-activating protein) adaptor implicated in both positive and negative immunoregulation and endocytosis [28], [46]. Recently however, antibody binding to pSn on PAM was shown to be associated with subtle alterations of MAPK (mitogen-activated protein kinase), adipocytokine and Wnt signaling and regulation of the actin cytoskeleton [47]. This indicates that antibody binding to pSn activates signaling in PAM, which could affect macrophage effector functions through interference with signaling pathways. So far, little is known about the role of Sn in the regulation of macrophage effector functions. Seen the gaining interest of using Sn as a targeting molecule, the growing number of cells and pathogens engaging Sn and the induction of signaling upon antibody binding to pSn, the present study aimed to characterize the effect of antibody binding to pSn on macrophage viability, sialoadhesin cell surface expression, phagocytosis of particulate antigens, uptake and processing of soluble antigens, reactive oxygen species (ROS) and reactive nitrogen species (RNS) production, MHC I and MHC II cell surface expression and cytokine production.
Section snippets
Cells and antibodies
Porcine primary alveolar macrophages (PAM) were obtained and cultivated as described earlier [48]. The IgG1 mouse monoclonal anti-porcine Sn antibody (mAb) 41D3 was used as a ligand to bind pSn and for visualization of pSn cell surface expression [39], [49]. MAb 13D12 was used as an isotype-matched irrelevant control mAb [50]. MHC I antigen was visualized using the IgG2a mouse mAb PT85A (VMRD, Pullman, WA, USA), directed against the heavy chain of MHC I. MHC II antigen was detected using the IgG
Antibody binding to pSn has no effect on macrophage viability
To assess the effect of antibody binding to pSn on macrophage viability, flow cytometry was performed upon live-dead staining of macrophages treated with the Sn-specific mAb 41D3. No differences in macrophage viability were detected for mAb 41D3 treated macrophages versus isotype-matched control mAb treated groups in response to all studied concentrations (Fig. 1A). In addition, treatment of macrophages with the highest mAb dose did not have any cytotoxic effect up to 72 h after starting the
Discussion
Macrophages are considered important target cells for selective elimination, activation or immunomodulation due to their importance in homeostasis and host defence, their migratory capacity, their implications in infectious diseases, cancer and inflammatory disorders and since immunity to a specific antigen might be modulated upon targeting of this antigen to antigen-presenting cells [58], [59], [60], [61], [62]. Since Sn is an endocytic receptor and given its restricted expression pattern,
Role of the funding source
M. De Baere was financially supported by the Flemish Institute for the Promotion of Innovation by Science and technology (I.W.T.-Flanders; SB 71434). H. Van Gorp was financially supported by a post-doctoral grant from the Special Research Fund of Ghent University. This research was further supported by the Industrial Research Fund (IOF) of Ghent University (www.techtransfer.ugent.be) and the Flemish Institute for the Promotion of Innovation by Science and Technology (IWT – SBO 80046) (www.iwt.be
Disclosure statement
Three authors (Miet De Baere, Peter L. Delputte and Hans J. Nauwynck) are listed as inventors on a patent application related to the work described in this study, which has been submitted through Ghent University.
Acknowledgments
We would like to thank C. Vanmaercke, C. Boone, D. Helderweirt, T. Van Gaever, L. Sys and N. Dennequin for excellent technical assistance, Professor H. Hammad for assistance with the confocal microscopical analysis, and Professor H.W. Favoreel and Dr. I. Hoebeke for their useful comments on the manuscript.
References (77)
- et al.
Alternative activation of macrophages: immune function and cellular biology
Immunobiology
(2009) - et al.
MHC molecules and microbial antigen processing in phagosomes
Curr. Opin. Immunol.
(2009) - et al.
Antigen presentation the macrophage way
Cell
(2007) - et al.
OB-BP1/Siglec-6 – a leptin- and sialic acid-binding protein of the immunoglobulin superfamily
J. Biol. Chem.
(1999) - et al.
Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations
Blood
(2001) - et al.
Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study
Atherosclerosis
(1999) - et al.
The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22
J. Biol. Chem.
(1995) - et al.
Identification of sialoadhesin as a dominant lymph node counter-receptor for mouse macrophage galactose-type C-type lectin 1
J. Biol. Chem.
(2004) - et al.
Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor
J. Biol. Chem.
(1999) - et al.
Siglecs as targets for therapy in immune-cell-mediated disease
Trends Pharmacol. Sci.
(2009)
Characterization of monoclonal antibodies directed against swine leukocytes
Vet. Immunol. Immunopathol.
Role of SPI-1 in the interactions of Salmonella typhimurium with porcine macrophages
Vet. Microbiol.
Interleukin-2 receptor signaling: at the interface between tolerance and immunity
Immunity
Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages
J. Control. Release
Therapeutic potential of nanoparticulate systems for macrophage targeting
Biomaterials
Quantitative nitric oxide production by rat, bovine and porcine macrophages
Nitric Oxide Biol. Chem.
Inducible nitric oxide synthase expression in porcine immune cells
Vet. Immunol. Immunopathol.
Fc gamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway
J. Biol. Chem.
Characterization and functional analysis of skin-derived dendritic cells from swine without a requirement for in vitro propagation
Vet. Immunol. Immunopathol.
Effect of transferrin on the degradation of glycoproteins bearing a hybrid or high-mannose glycan by alveolar macrophages
Exp. Cell Res.
Porcine alveolar macrophages: poor accessory or effective suppressor cells for T-lymphocytes
Vet. Immunol. Immunopathol.
Monocyte and macrophage heterogeneity
Nat. Rev. Immunol.
The multiple roles of monocyte subsets in steady state and inflammation
Cell. Mol. Life Sci.
Toll-like receptors in the induction of the innate immune response
Nature
Phagocytosis and the inflammatory response
J. Infect. Dis.
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity
J. Clin. Invest.
Alternative activation of macrophages
Nat. Rev. Immunol.
Macrophage signaling and respiratory burst
Immunol. Res.
Macrophage activation by endogenous danger signals
J. Pathol.
CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes
Nat. Immunol.
Phagocytosis: at the crossroads of innate and adaptive immunity
Annu. Rev. Cell Dev. Biol.
The who, how and where of antigen presentation to B cells
Nat. Rev. Immunol.
Macrophage receptors and immune recognition
Annu. Rev. Immunol.
Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages
J. Exp. Med.
Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody
J. Exp. Med.
Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule
J. Exp. Med.
Siglecs: a family of sialic-acid binding lectins
Glycobiology
Siglecs and their roles in the immune system
Nat. Rev. Immunol.
Cited by (4)
Monoclonal antibody binding to the macrophage-specific receptor sialoadhesin alters the phagocytic properties of human and mouse macrophages
2017, Cellular ImmunologyCitation Excerpt :Alveolar macrophages are important cells for a first defense and are therefore considered to be more actively phagocytosing cells. Interestingly, in porcine alveolar macrophages phagocytosis of beads is drastically reduced upon treatment with Sn-specific mAbs, which is in contrast with the results observed in our experiments [8]. Intriguingly, although mean values of the number of phagocytosed beads were identical between controls and anti-Sn mAbs treated cells, we could identify two different patterns of phagocytosis in mouse alveolar macrophages.
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
2013, Proceedings of the National Academy of Sciences of the United States of America
- 1
Joint senior authorship.